Infographic: The facts about Zika
Take a look at our infographic below to learn more about this emerging virus and find out key facts about Zika infection.
Browsing: virus
Zika virus update: a note from the Editor
18 months on from the WHO’s declaration of a Public Health Emergency, we provide an update on Zika, including a research round-up and vaccine pipelines.
What can climate-driven models teach us about the Zika outbreak?
Environmental change, and a growing and more connected population will promote vector-borne disease risk further. In this opinion piece, the authors discuss the role of climate modeling in disease prediction and epidemiology.
Zika – an update on the vaccine pipeline
Is a Zika vaccine imminent? Martha Powell provides an overview of the current Zika vaccine candidates in human clinical trials and how these vaccines are being assessed.
Zika virus: where are we now?
How researchers and physicians have risen to the Zika challenge a short year and half after the WHO declared a public health emergency.
Human herpes virus 6 may hamper the brain’s ability to repair damaged cells
Researchers discover latent human herpes virus 6 may interfere with the brains ability to repair damaged myelin in brain diseases such as multiple sclerosis.
Zika virus to be investigated as novel glioblastoma treatment
A new first-of-its-kind study will assess Zika virus as a tool to target glioblastomas, one of the most challenging cancers to treat.
Researchers uncover how Zika virus might cross the placental barrier
Researchers have uncovered a mechanism utilized by Zika virus to cross the placental barrier; this has provided an insight into the virus’ ability to cause birth defects such as microcephaly.
NCTalks with Patricia Garcez: the hijacking effect of Zika virus
In this interview, Patricia Garcez discusses her work on Zika virus and its disruption of normal cell division and differentiation, and her hopes for the field in the coming months and years.
New study links HIV antiretroviral drugs to neuronal degeneration
Researchers have demonstrated a widely used HIV therapy, protease inhibitors, might induce cell stress, leading to the production of beta amyloid and contributing to HIV-associated neurocognitive disorders.
